| Pharmaceutical active ingredients: |
| Amphotericin B Liposomal |
| Available forms, composition and doses of Anfogen: |
| N / A |
| Anfogen medical category: |
| Human:AntifungalsPolyenesSystemic antibioticsTreatment of mycotic infections |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A01AB04 - Amphotericin BA07AA07 - Amphotericin BG01AA03 - Amphotericin BJ02AA01 - Amphotericin B |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Richmond Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Anflat | Simethicone | Cazi Quimica Farmaceutica Industria e Comercio |
| Anflatox | Meloxicam | Psicofarma Laboratorio |
| Anflene | Piroxicam | Teuto-Brasileiro Laboratorio |
| Anfloxin | Acetaminophen; Ketoprofen | Degort's Chemical |
| Anfocort | Amphotericin B; Halcinonide | Bristol-Myers Squibb |
| Anfokali | Cistus Canadensis; Guajacum; Lobaria Pulmonaria | Mag. J. Bano Chemische Pharmazeutische Praparate |
| Anfolic | Folic Acid | TRB Pharma |
| Anfomicin | Benzocaine; Neomycin Sulfate; Sulfadiazine; Tyrothricin | Windson Produtos Quimicos e Farmaceuticos |
| Anforicin B | Amphotericin B | Cristalia Produtos Quimicos Farmaceuticos |
| Anforstan | Potassium Chlorate | Unidentified Pharmaceutical Company |